ClinConnect ClinConnect Logo
Search / Trial NCT06828185

Patient Reported Experiences With Sparing External Oblique Fascia Vs Standard Inguinal Orchiectomy

Launched by LOMA LINDA UNIVERSITY · Feb 10, 2025

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Orchiectomy Postoperative Pain Testis Cancer Germ Cell Tumors

ClinConnect Summary

This clinical trial is looking at two surgical methods for removing a testicle in men who might have testicular cancer. The goal is to see if one method, which spares a layer of tissue called the external oblique fascia, leads to less pain, fewer complications, and reduced need for pain medication compared to the standard surgical approach. This study will help doctors understand which method might be better for patients in terms of recovery and comfort after surgery.

To participate in this trial, men aged 18 and older who are scheduled for this type of surgery may be eligible, provided they do not have certain health issues like a recent history of opioid use or specific cancer stages. Participants will be asked about their experiences after surgery, including pain levels and any complications they may face. This information can help improve care for future patients undergoing similar procedures. The trial is not yet recruiting participants but aims to gather important insights into post-surgery recovery for testicular cancer patients.

Gender

MALE

Eligibility criteria

  • Inclusion Criteria:
  • Participants undergoing radical orchiectomy for suspected testicular malignancy
  • Testicular malignancy can be germ cell tumor or non germ cell tumors, including paratesticular tumors as long as a radical orchiectomy is planned
  • Participants over 18 years of age who can provide informed consent
  • Participants not currently using opiates for another reason
  • Regional and metastatic patients are allowed, as long as participant does not require opiates for pain related to metastatic disease
  • No contraindication for participant to receive standardized medication pathway in the peri-operative period.
  • Exclusion Criteria:
  • Clinical T4 disease
  • History of illicit substance abuse (including prior opioid abuse) except for marijuana
  • Participants who underwent chemotherapy or radiotherapy prior to orchiectomy
  • Opioid use within 1 month of study enrollment
  • Participants with large testis masses requiring skin incision larger than 8 cm in size.
  • Participants with large testis masses requiring orchiectomy through an incision other than the standard transverse inguinal incision (i.e. hockey stick incision, vertical incision)

About Loma Linda University

Loma Linda University is a prominent academic institution dedicated to advancing health and wellness through innovative research and education. As a sponsor of clinical trials, Loma Linda University leverages its extensive medical and scientific expertise to conduct rigorous studies aimed at improving patient outcomes and public health. With a commitment to ethical practices and patient safety, the university collaborates with a diverse network of healthcare professionals and researchers to explore novel therapeutic interventions and enhance clinical knowledge across various medical disciplines. Through its clinical trials, Loma Linda University seeks to contribute valuable insights to the medical community and foster advancements in healthcare delivery.

Locations

Loma Linda, California, United States

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported